NEW YORK (GenomeWeb) – Molecular diagnostics firm Lineagen today announced the close of the second and final tranche of its Series C financing round that brought in a total of $15.8 million. 

The second tranche raised about $12.2 million and follows a $3.5 million first tranche that the Salt Lake City-based firm raised in December 2013. Lineagen said that it also received a $4 million secured debt facility with Silicon Valley Bank as part of the initial tranche.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A federal grand jury has indicted Elizabeth Holmes and Ramesh Balwani for alleged wire fraud in conjunction with their activities at Theranos.

Nature News reports that some developers are nervous about GitHub's acquisition by Microsoft.

A direct-to-consumer genetic testing company sent out used spit kits, CNBC reports.

In PLOS this week: comparison of commercial bisulfite kits, new method to predict essential proteins, and more